  Endothelial dysfunction induced by Angiotensin II ( AG II) plays an important role in the pathogenesis of hypertension and is accompanied by a prooxidative condition , which in turn induces an inflammatory state , vascular remodeling , and tissue damage including the kidney ( Schmitt and Dirsch , 2009) ( 1). New drugs that can control several of these pathologies are required.